2 COVID-19 vaccines could be authorized this month. Can we choose which one we get?

The U.S. is potentially weeks away from having not one, but two COVID-19 vaccines administered in the arms of at least 20 million people by the end of the month — with more candidates on the horizon. But the availability of multiple vaccines doesn’t necessarily mean you’ll be able to pick for yourself — as staggered roll outs, various storage requirements and other unknowns will likely complicate the process. Pfizer and its partner, BioNTech, along with Moderna, are in line for U.S. Food and Drug Administration authorization on Dec. 10 and Dec. 17, respectively. If given the green light, Pfize…

Read More

HEDGE accordingly